INTRODUCTION
In 1998 the neuro-immuno-cutaneous-endocrine model was suggested to explain the mind and body connection (O Sullivan et al. 1998) . That model explains how many inflammatory dermatoses, such as psoriasis, are triggered or exacerbated by stress factors, including psychological stress and social environment. These conditions are called psychophysiological skin disorders (Yadav et al. 2013 ). There is an embryological and biochemical relationship between the brain and the skin (Chen & Lyga 2014) which could also explain the high prevalence of psychopathology in patients with chronic skin diseases, such as in psoriasis.
Psoriasis is a chronic inflammatory skin disease with profound negative psychosocial impact, with social stigma, affecting approximately 2% of the population worldwide (Ni & Chiu 2014) . It is a psychophysiological skin disorder with several psychiatric comorbidities. Actually, patients with psoriasis exhibit numerous important psychiatric diseases more often than expected (Boehncke & Boehncke 2014 ). Several papers have pointed out the link between psoriasis and psychological stress as well as its connection with some mental disorders, specially depression and anxiety. However, the clinical practice has shown that these patients may have many other important mental disorders. Though, for many mental disorders and psychopathological aspects found in patients with psoriasis there has been scarce analysis. But the psychiatric morbidity in psoriasis is often a more important indicator of the disability experienced by the patient than the dermatologic aspects of the disorder (Gupta & Gupta 2003) .
Based on the information above, this systematic review sets out to analyse the literature about the prevalence of psychiatric comorbidities in psoriasis.
between psychological stress and psoriasis were included. We considered the articles about prevalence and clinical aspects. Only the studies with humans published in English, French, German, Portuguese and Spanish were selected. The date restrictions were between 1990 and February 2015. All study designs were included.
Search Strategy
The search was performed in February 2015 and it followed the 5S model of evidence based on information services (Haynes 2006) . The top level of evidence, systems, was not used because it was not completely developed. Therefore, the first level used in this review was summaries, in UpToDate, using the words "psoriasis" and "psychopathology" and "psoriasis" and "mental disorders". At the next level, synopses, the search was in the Evidence Based Medicine database, with the same words. Afterwards, we used the syntheses level, through the Cochrane Library. Finally, at the studies level, the search was conducted in the Medical Subject Headings (MeSH) of PubMed. The search strategy was the conjunction of the following terms: "Mental Disorders AND Psoriasis", "Stress, Psychological AND Psoriasis" and "Psychopathology AND Psoriasis".
Process of Data Collection and Analysis
The titles and abstracts obtained from this search were reviewed and selected when they followed the inclusion criteria. After this process, we considered 34 papers. They were then deeply analysed, considering the following topics: mental disorders found in patients with psoriasis and their prevalence; the main clinical features of the psychopathology linked with psoriasis. The results were analysed through Stata statistical software 13.1 (stataCorp LP, Texas).
RESULTS
The search provided 390 papers. The levels from the top of the Haynes pyramid of evidence did not retrieve articles about this topic. This shows that there is no other article which globally analyses the prevalence of all the mental disorders that are linked with psoriasis.
After applying the inclusion criteria, 34 papers from the studies level were included. Table 1 exposes these articles and the characteristics of each study: there are five reviews about some of the psychiatric comorbidities of psoriasis, one systematic review about the prevalence of sexual dysfunction, 12 case-control studies, 14 cross-sectional and 2 cohort studies. Table 2 compiles the specific type of mental disorder that was described by the papers selected, the main group of the psychiatric disorders according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), to which we can attach the comorbidity mentioned and the respective prevalence. Depressive symptoms have been described in a high frequency as well (up to 68%). Among mood disorders, depressive disorders are the most prevalent. On the other hand, borderline personality disorder was found to be an important psychiatric comorbidity in these patients (17.5%), but other personality disorders were described in an important prevalence too. According to the results of this systematic review, there is some evidence of a relationship between schizophrenia and other psychoses and psoriasis (Crosta et ) and the prevalence may reach 35%. Furthermore, sexual dysfunction and sleep disorders have the highest frequency in these patients. Sexual dysfunction may be present in more than 20.9% of the patients with psoriasis and the frequency may reach 71.3%. A decreased sexual desire as well as orgasmic disorder and erectile dysfunction are all prevalent. Sleep disorders are found in more than 56.6% of the psoriasis cases. Regarding the problem of somatic symptoms and related disorders, 39% of the patients with psoriasis have somatization complaints. Finally, from this systematic search we may expect that 68% also have nicotine dependence and up to 32% of patients with psoriasis may have problems with alcohol. Mazzetti M Cross-sectional 80 -*this number does not represent the number of patients with psoriasis but the number of patients with a psychiatric diagnosis (in this case, schizophrenia) who were studied to define the risk for psoriasis Table 3 presents the main psychiatric diagnoses and the respective average prevalence and standard deviation among the different studies. After assessing all the results from the papers selected, it could be concluded that sleep disorders are the main comorbidity of these patients, followed by sexual dysfunction, personality disorders and then anxiety, adjustment and depressive disorders. We did not find any paper about the exact prevalence of any specific diagnosis (according to the DSM-5) of eating disorders in psoriasis. Nevertheless, in spite of this fact, some symptoms of eating disorders, namely body dissatisfaction and interpersonal distrust, are exhibited by psoriasis patients and are statistically relevant, as observed by Crosta et al. 2014 . The authors also highlighted previous studies which pointed out binge eating disorder as an important eating disorder in psoriasis.
Other specific psychopathological aspects were also described, namely alexithymia ( 
DISCUSSION
Chronic skin diseases, such as psoriasis, have a high impact on the patients' health related quality of life, with high levels of psychological morbidity. Skin disorders, highly visible, can devastate self-esteem and cause feelings of shame, with impact on mental health and social life. Besides, some skin diseases, such as psoriasis, are also worsened by stressful life events.
The results of this systematic review point out that the prevalence of psychiatric disorders in psoriasis may range from 24% to 90%. Therefore, mental disorders are an important part of the problem of psoriasis.
Most of the studies have been focused on depression and anxiety as well as on how the psychological impact of psoriasis and social disability can worsen the skin disease. Apart from these two important psychiatric comorbidities of psoriasis (depression and anxiety),
Bárbara Roque Ferreira, José Luís Pio-Abreu, José Pedro Reis & Américo Figueiredo: ANALYSIS OF THE PREVALENCE OF MENTAL DISORDERS IN PSORIASIS: THE RELEVANCE OF A PSYCHIATRIC ASSESSMENT IN DERMATOLOGY
Psychiatria Danubina, 2017; Vol. 29, No. 4, pp 401-406 there is often a considerable psychiatric background.
From this systematic review we may say that sleep disorders are the main psychiatric comorbidity of psoriasis and the etiology could be multifactorial. Moreover, these patients may also have substancerelated, personality and eating disorders. Patients with psoriasis often exhibit destructive mechanisms of coping, such as drinking alcohol, smoking and overeating (Basavaraj et al. 2011) .
Considering the high prevalence of metabolic syndrome in psoriasis, it would be important to know how far it is related to an underlying eating disorder. In this case, eating disorders should be explored in the dermatologic practice and their approach should be the first step to deal with the problem of overweight in patients with psoriasis.
Some studies suggest that there is a link between psoriasis and psychoses too (Crosta et However, the literature in this field is scarce and sometimes it lacks rigorous analysis. Actually, the definition of the kind of psychosis is not always clear both in the clinical practice and in the papers published. This fact is especially evident in the case of psychoses/schizophrenia but it also happens with many other mental disorders. An imprecise description of the psychiatric diagnosis may difficult a rigorous analysis about the prevalence and its connection with psoriasis.
CONCLUSION
The boundary between Psychiatry and Dermatology is a ripe field of research, with clinical relevance. In psoriasis, the skin changes are the "tip of the iceberg", which means that these patients should be analysed in a deeper way.
Future research should include more studies about the prevalence of the least studied comorbidities, such as the prevalence of eating disorders or psychoses in psoriasis. The aim would be to confirm what kind of psychoses and how strong they are connected with psoriasis as well as in which conditions they may happen. The problem of eating disorders in psoriasis and their theoretical relationship with the high prevalence of metabolic syndrome and cardiovascular disease in psoriasis deserves further research and, perhaps, new treatment strategies. Moreover, it would be interesting to explore the clinical differences, in psychopathology, that have been suggested between psoriasis of early and late onset in order to stablish whether or not they require different approach. Finally, the high prevalence of psychiatric comorbidities in psoriasis suggests that these patients benefit from a psychodermatologic approach in dermatologic practice. They would benefit from a psychiatric assessment, determining the scores of anxiety or depression, the impact of the skin disease on quality of life as well as the kind of psychopathology and mental disorders the patient has. After this assessment, a better treatment strategy, a truly biopsychosocial treatment, could be suggested.
